1. Home
  2. ARDX vs AFYA Comparison

ARDX vs AFYA Comparison

Compare ARDX & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • AFYA
  • Stock Information
  • Founded
  • ARDX 2007
  • AFYA 1999
  • Country
  • ARDX United States
  • AFYA Brazil
  • Employees
  • ARDX N/A
  • AFYA N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • AFYA Other Consumer Services
  • Sector
  • ARDX Health Care
  • AFYA Real Estate
  • Exchange
  • ARDX Nasdaq
  • AFYA Nasdaq
  • Market Cap
  • ARDX 1.4B
  • AFYA 1.5B
  • IPO Year
  • ARDX 2014
  • AFYA 2019
  • Fundamental
  • Price
  • ARDX $5.06
  • AFYA $17.35
  • Analyst Decision
  • ARDX Buy
  • AFYA Sell
  • Analyst Count
  • ARDX 8
  • AFYA 5
  • Target Price
  • ARDX $9.93
  • AFYA $18.00
  • AVG Volume (30 Days)
  • ARDX 3.6M
  • AFYA 110.2K
  • Earning Date
  • ARDX 02-20-2025
  • AFYA 03-13-2025
  • Dividend Yield
  • ARDX N/A
  • AFYA N/A
  • EPS Growth
  • ARDX N/A
  • AFYA 62.61
  • EPS
  • ARDX N/A
  • AFYA 1.17
  • Revenue
  • ARDX $333,615,000.00
  • AFYA $584,951,886.00
  • Revenue This Year
  • ARDX $169.30
  • AFYA $17.42
  • Revenue Next Year
  • ARDX $14.87
  • AFYA $12.85
  • P/E Ratio
  • ARDX N/A
  • AFYA $14.82
  • Revenue Growth
  • ARDX 168.06
  • AFYA 16.67
  • 52 Week Low
  • ARDX $4.32
  • AFYA $14.52
  • 52 Week High
  • ARDX $9.83
  • AFYA $22.24
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 41.70
  • AFYA 59.58
  • Support Level
  • ARDX $5.37
  • AFYA $16.55
  • Resistance Level
  • ARDX $6.55
  • AFYA $18.05
  • Average True Range (ATR)
  • ARDX 0.31
  • AFYA 0.43
  • MACD
  • ARDX -0.02
  • AFYA 0.08
  • Stochastic Oscillator
  • ARDX 0.67
  • AFYA 70.71

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

Share on Social Networks: